BiomX PHGE
NYSE PHGE
$0.14 0.00 (-1.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

BiomX (PHGE) Consolidated Net Income (2018 - 2026)

BiomX (PHGE) posted Consolidated Net Income of -$19.1 million for Q1 2026, down 204.49% sequentially from $18.3 million in Q4 2025, and down 149.9% YoY from $38.4 million in Q1 2025.

BiomX (PHGE) Consolidated Net Income (2018 - 2026) Analysis & Trends

BiomX has reported Consolidated Net Income for 9 years, with the latest figure at -$19.1 million in Q1 2026.

  • Quarterly Consolidated Net Income fell 149.9% year-over-year to -$19.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.0 million (down 194.83% YoY) and the FY2025 annual result came in at -$4.5 million, down 162.85% from the prior year.
  • Consolidated Net Income fell to -$19.1 million in Q1 2026 per PHGE's latest filing, from $18.3 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $18.3 million in Q4 2025 and troughed at -$19.1 million in Q1 2026.
  • A 5-year average of -$2.0 million and a median of -$6.4 million in 2023 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2024 and 2025: Consolidated Net Income surged 290.22% in 2024, then slumped 235.03% in 2025.
  • Over 5 years, Consolidated Net Income stood at $15.4 million in 2022, then sank by 135.71% to -$5.5 million in 2023, then soared by 290.22% to $10.4 million in 2024, then surged by 75.37% to $18.3 million in 2025, then tumbled by 204.49% to -$19.1 million in 2026.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered -$19.1 million, $18.3 million, and -$9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -174.37 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 BiomX 351,774.34 -816,225.66 - -19.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.14 Mn
Dec 31, 2025 18.32 Mn
Sep 30, 2025 -9.17 Mn
Jun 30, 2025 -6.04 Mn
Mar 31, 2025 -7.66 Mn
Dec 31, 2024 10.45 Mn
Sep 30, 2024 9.64 Mn
Jun 30, 2024 4.47 Mn
Dec 31, 2023 -5.49 Mn
Sep 30, 2023 -7.91 Mn
Jun 30, 2023 -6.41 Mn
Mar 31, 2023 -6.36 Mn
Dec 31, 2022 15.38 Mn
Sep 30, 2022 -6.78 Mn
Jun 30, 2022 -7.48 Mn
Mar 31, 2022 -8.17 Mn
Dec 31, 2021 -10.46 Mn
Sep 30, 2021 -10.03 Mn
Jun 30, 2021 -7.34 Mn
Mar 31, 2021 -8.40 Mn